This compound is a pharmaceutical intermediate used in the manufacturing of alpha1-adrenergic blockers. It serves as a key intermediate for the production of medications such as alfuzosin, prazosin, terazosin, doxazosin, and IAAP, which are effective as antihypertensives.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 28888-44-0
Lifitegrast Impurity 125
pharmaceutical intermediate
N-[5-(Diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide
pharmaceutical intermediate
Tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetate
pharmaceutical intermediate
N-nitroso-tamsulosin
pharmaceutical intermediate
8-Bromoquinazoline-2,4-diol
research compound
6-Bromoquinazoline-2,4-dione
pharmaceutical intermediate
8-Chloro-6-fluoroquinazoline-2,4-diol
pharmaceutical intermediate
7-Bromo-8-fluoro-6-(trifluoromethyl)quinazoline-2,4(1H,3H)-dione
pharmaceutical intermediate
6,7-dimethoxy-1H-quinazoline-2,4-dione
KWNQIIMVPSMYEM-UHFFFAOYSA-N
COC1=C(C=C2C(=C1)C(=O)NC(=O)N2)OC